ORASURE TECHNOLOGIES INC (OSUR) Stock Price & Overview

NASDAQ:OSURUS68554V1089

Current stock price

3.05 USD
+0.05 (+1.67%)
At close:
3.05 USD
0 (0%)
After Hours:

The current stock price of OSUR is 3.05 USD. Today OSUR is up by 1.67%. In the past month the price increased by 1.33%. In the past year, price decreased by -1.93%.

OSUR Key Statistics

52-Week Range2.08 - 3.82
Current OSUR stock price positioned within its 52-week range.
1-Month Range2.78 - 3.45
Current OSUR stock price positioned within its 1-month range.
Market Cap
210.847M
P/E
N/A
Fwd P/E
N/A
EPS (TTM)
-0.93
Dividend Yield
N/A

OSUR Stock Performance

Today
+1.67%
1 Week
-2.87%
1 Month
+1.33%
3 Months
+28.15%
Longer-term
6 Months -4.09%
1 Year -1.93%
2 Years -42.34%
3 Years -55.15%
5 Years -66.67%
10 Years -57.52%

OSUR Stock Chart

ORASURE TECHNOLOGIES INC / OSUR Daily stock chart

OSUR Technical Analysis

ChartMill assigns a technical rating of 6 / 10 to OSUR. When comparing the yearly performance of all stocks, OSUR turns out to be only a medium performer in the overall market: it outperformed 64.42% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

OSUR Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to OSUR. While OSUR seems to be doing ok healthwise, there are quite some concerns on its profitability.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

OSUR Earnings

On February 25, 2026 OSUR reported an EPS of -0.27 and a revenue of 26.76M. The company missed EPS expectations (-29.12% surprise) and missed revenue expectations (-0.77% surprise).

Next Earnings DateMay 5, 2026
Last Earnings DateFeb 25, 2026
PeriodQ4 / 2025
EPS Reported-$0.27
Revenue Reported26.763M
EPS Surprise -29.12%
Revenue Surprise -0.77%

OSUR Forecast & Estimates

9 analysts have analysed OSUR and the average price target is 4.08 USD. This implies a price increase of 33.77% is expected in the next year compared to the current price of 3.05.

For the next year, analysts expect an EPS growth of 23.23% and a revenue growth 2.71% for OSUR


Analysts
Analysts80
Price Target4.08 (33.77%)
EPS Next Y23.23%
Revenue Next Year2.71%

OSUR Groups

Sector & Classification

OSUR Financial Highlights

Over the last trailing twelve months OSUR reported a non-GAAP Earnings per Share(EPS) of -0.93. The EPS decreased by -257.69% compared to the year before.


Income Statements
Revenue(TTM)115.02M
Net Income(TTM)-68.73M
Industry RankSector Rank
PM (TTM) N/A
ROA -17.05%
ROE -20.17%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%-92.86%
Sales Q2Q%-28.53%
EPS 1Y (TTM)-257.69%
Revenue 1Y (TTM)-38.1%

OSUR Ownership

Ownership
Inst Owners86.51%
Shares69.13M
Float64.41M
Ins Owners5.58%
Short Float %5.47%
Short Ratio6.7

About OSUR

Company Profile

OSUR logo image OraSure Technologies, Inc. engages in the development, manufacture, and distribution of point of care diagnostic tests and molecular collection devices designed to detect or diagnose critical medical conditions. The company is headquartered in Bethlehem, Pennsylvania and currently employs 500 full-time employees. The firm improves the access, quality, and value of healthcare with innovation in effortless tests and sample management solutions. The Company, together with its wholly owned subsidiaries, DNA Genotek Inc. and Sherlock Biosciences, Inc., is engaged in the development, manufacture, and distribution of rapid diagnostic tests and sample collection and stabilization devices designed to discover and detect critical medical conditions. Its portfolio of products is sold globally to clinical laboratories, hospitals, physician’s offices, clinics, public health and community-based organizations, research institutions, government agencies, pharmaceutical companies, and direct consumers. Its products and services include OraQuick ADVANCE Rapid HIV1/2 Antibody Test, OraQuick HIV Self-Test, and Diagnostics Direct Syphilis Health Check.

Company Info

IPO: 1986-11-17

ORASURE TECHNOLOGIES INC

220 E First St

Bethlehem PENNSYLVANIA 18015 US

CEO: Stephen S. Tang

Employees: 500

OSUR Company Website

OSUR Investor Relations

Phone: 13026587581

ORASURE TECHNOLOGIES INC / OSUR FAQ

What does ORASURE TECHNOLOGIES INC do?

OraSure Technologies, Inc. engages in the development, manufacture, and distribution of point of care diagnostic tests and molecular collection devices designed to detect or diagnose critical medical conditions. The company is headquartered in Bethlehem, Pennsylvania and currently employs 500 full-time employees. The firm improves the access, quality, and value of healthcare with innovation in effortless tests and sample management solutions. The Company, together with its wholly owned subsidiaries, DNA Genotek Inc. and Sherlock Biosciences, Inc., is engaged in the development, manufacture, and distribution of rapid diagnostic tests and sample collection and stabilization devices designed to discover and detect critical medical conditions. Its portfolio of products is sold globally to clinical laboratories, hospitals, physician’s offices, clinics, public health and community-based organizations, research institutions, government agencies, pharmaceutical companies, and direct consumers. Its products and services include OraQuick ADVANCE Rapid HIV1/2 Antibody Test, OraQuick HIV Self-Test, and Diagnostics Direct Syphilis Health Check.


What is the current price of OSUR stock?

The current stock price of OSUR is 3.05 USD. The price increased by 1.67% in the last trading session.


Does OSUR stock pay dividends?

OSUR does not pay a dividend.


How is the ChartMill rating for ORASURE TECHNOLOGIES INC?

OSUR has a ChartMill Technical rating of 6 out of 10 and a ChartMill Fundamental rating of 3 out of 10.


On which exchange is OSUR stock listed?

OSUR stock is listed on the Nasdaq exchange.


What is the GICS sector and industry of OSUR stock?

ORASURE TECHNOLOGIES INC (OSUR) operates in the Health Care sector and the Health Care Equipment & Supplies industry.


Can you provide the market cap for ORASURE TECHNOLOGIES INC?

ORASURE TECHNOLOGIES INC (OSUR) has a market capitalization of 210.85M USD. This makes OSUR a Micro Cap stock.